Taken together, our study elucidates the molecular mechanism underlying CDK9 inhibitor-induced SL in APC-deficient cells, providing novel insights into CRC pathogenesis and the development of innovative treatment strategies. This evidence concerns the gene APC and colorectal carcinoma.